Buprenorphine Provision by Early Career Family Physicians.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30201642.
- Also identified by DOI 10.1370/afm.2261 and PMC identifier 6130986.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Buprenorphine can be used in primary care to treat opioid use disorder, but many family physicians feel unprepared to care for patients with opioid addiction. We sought to describe preparedness to provide and current provision of buprenorphine treatment by early career family physicians using data from the 2016 National Family Medicine Graduate Survey. Of 1,979 respondents, 10.0% reported preparedness to provide buprenorphine treatment, and 7.0% reported current buprenorphine provision. Residency preparation to provide buprenorphine treatment was most highly associated with current provision (odds ratio = 13.50; 95% CI, 7.59-24.03). Efforts to increase buprenorphine training may alleviate the workforce shortage to treat opioid use disorder.
Medical subject headings
- Buprenorphine
- Family Practice
- Narcotic Antagonists
- Opiate Substitution Treatment
- Opioid-Related Disorders
- Physicians, Family